Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract

Cancer Treat Rep. 1984 Nov;68(11):1415-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Daunorubicin / adverse effects
  • Daunorubicin / analogs & derivatives*
  • Daunorubicin / therapeutic use
  • Drug Evaluation
  • Esophageal Neoplasms / drug therapy*
  • Humans
  • Idarubicin
  • Stomach Neoplasms / drug therapy*

Substances

  • Idarubicin
  • Daunorubicin